149 related articles for article (PubMed ID: 7301597)
1. The synthesis and properties of some 5-substituted uracil derivatives.
Walker RT; Jones AS; Rahim SG; Serafinowski P; De Clercq E
Nucleic Acids Symp Ser; 1981; (9):21-4. PubMed ID: 7301597
[TBL] [Abstract][Full Text] [Related]
2. The synthesis and properties of some 5-substituted uracil derivatives.
Walker RT; Jones AS; De Clercq E; Descamps J; Allaudeen HS; Kozarich JW
Nucleic Acids Symp Ser; 1980; (8):s95-102. PubMed ID: 7019862
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of herpes simplex viruses, type 1 (HSV-1) an type 2 (HSV-2), by (E)-5-(2-X-vinyl)-2'-deoxyuridines.
de Clercq E; Verhelst G; Descamps J; Bergstrom DE
Acta Microbiol Acad Sci Hung; 1981; 28(3):307-12. PubMed ID: 6272553
[No Abstract] [Full Text] [Related]
4. Synthesis and biological activity of 5-(2,2-difluorocyclopropyl)-2'-deoxyuridine deoxyuridine diastereomers.
Tandon M; Singh S; Xu L; Kumar P; Wiebe LI; Knaus EE; Gati WP; Tempest ML
Drug Des Discov; 1992; 9(1):79-91. PubMed ID: 1333829
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral properties of (Z)-5-(2-bromovinyl)-2'-deoxyuridine.
Jones AS; Rahim SG; Walker RT; De Clercq E
J Med Chem; 1981 Jun; 24(6):759-60. PubMed ID: 6265638
[TBL] [Abstract][Full Text] [Related]
6. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication.
Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P
J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiviral activity of the enantiomeric forms of carba-5-iodo-2'-deoxyuridine and carba-(E)-5-(2-bromovinyl)-2'-deoxyuridine.
Balzarini J; Baumgartner H; Bodenteich M; De Clercq E; Griengl H
J Med Chem; 1989 Aug; 32(8):1861-5. PubMed ID: 2547072
[TBL] [Abstract][Full Text] [Related]
8. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
De Clercq E
Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733
[TBL] [Abstract][Full Text] [Related]
9. Deoxyribosyl exchange reactions leading to the in vivo generation and regeneration of the antiviral agents (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5-ethyl-2'-deoxyuridine and 5-(2-chloroethyl)-2'-deoxyuridine.
Desgranges C; De Clercq E; Razaka G; Drouillet F; Belloc I; Bricaud H
Biochem Pharmacol; 1986 May; 35(10):1647-53. PubMed ID: 3011010
[TBL] [Abstract][Full Text] [Related]
10. Effects of E-5-(2-bromovinyl)-2'-deoxyuridine and other selective anti-herpes compounds on the induction of retrovirus particles in mouse BALB/3T3 cells.
De Clercq E; Heremans H; Descamps J; Verhelst G; De Ley M; Billiau A
Mol Pharmacol; 1981 Jan; 19(1):122-9. PubMed ID: 7207456
[No Abstract] [Full Text] [Related]
11. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
[TBL] [Abstract][Full Text] [Related]
12. (E)-5-(2'-bromovinyl)-2'-deoxyuridine inhibition of macropodid herpesvirus 1 in vitro.
Smith GA; Whalley JM
J Zoo Wildl Med; 1998 Jun; 29(2):157-9. PubMed ID: 9732029
[TBL] [Abstract][Full Text] [Related]
13. 2'-Fluorinated arabinonucleosides of 5-(2-haloalkyl)uracil: synthesis and antiviral activity.
Griengl H; Wanek E; Schwarz W; Streicher W; Rosenwirth B; De Clercq E
J Med Chem; 1987 Jul; 30(7):1199-204. PubMed ID: 3037079
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.
De Clercq E; Desgranges C; Herdewijn P; Sim IS; Jones AS; McLean MJ; Walker RT
J Med Chem; 1986 Feb; 29(2):213-7. PubMed ID: 3005566
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral properties of some 2'-deoxy-5-(fluoroalkenyl)uridines.
Coe PL; Harnden MR; Jones AS; Noble SA; Walker RT
J Med Chem; 1982 Nov; 25(11):1329-34. PubMed ID: 6292425
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and antimetabolite properties of 5-substituted 2'-deoxyuridines. Anomeric 5-(2-aminohexafluoroprop-2-yl)- and 5-(2-trifluoroacetylaminohexafluoroprop-2-yl)-2'-deoxyuridine].
Mel'nik SIa; Bakhmedova AA; Iartseva IV; Kochetkova MV; Preobrazhenskaia MN
Bioorg Khim; 1987 Jul; 13(7):934-9. PubMed ID: 3675641
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
Peyron C; Benhida R; Bories C; Loiseau PM
Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
[TBL] [Abstract][Full Text] [Related]
18. Pyrazolopyridines with potent activity against herpesviruses: effects of C5 substituents on antiviral activity.
Gudmundsson KS; Johns BA; Allen SH
Bioorg Med Chem Lett; 2008 Feb; 18(3):1157-61. PubMed ID: 18086523
[TBL] [Abstract][Full Text] [Related]
19. [Antiviral activity of anomeric 5-substituted 2'-deoxyuridines].
Bektemirov TA; Chekunova EV; Andzhaparidze OG; Mel'nik SIa; Bakhmedova AA
Vopr Virusol; 1979; (6):603-6. PubMed ID: 524857
[TBL] [Abstract][Full Text] [Related]
20. The synthesis and biological properties of some 5-substituted-2'-deoxyuridines.
Walker RT; Slater MJ; Jones AS; Balzarini J; De Clercq E
Nucleic Acids Symp Ser; 1985; (16):291-4. PubMed ID: 4088880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
